|
Volumn 161, Issue 3, 2004, Pages 564-566
|
Preliminary Randomized, Double-Blind, Placebo-Controlled Trial of Pramipexole Added to Mood Stabilizers for Treatment-Resistant Bipolar Depression
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICONVULSIVE AGENT;
ANTIDEPRESSANT AGENT;
CARBAMAZEPINE;
CLONAZEPAM;
DOPAMINE RECEPTOR STIMULATING AGENT;
FLUOXETINE;
GABAPENTIN;
HOMOVANILLIC ACID;
LAMOTRIGINE;
LITHIUM;
LORAZEPAM;
MONOAMINE OXIDASE INHIBITOR;
MOOD STABILIZER;
NEUROLEPTIC AGENT;
PLACEBO;
PRAMIPEXOLE;
TOPIRAMATE;
TRICYCLIC ANTIDEPRESSANT AGENT;
UNCLASSIFIED DRUG;
VALPROATE SEMISODIUM;
ADULT;
ARTICLE;
BIPOLAR DEPRESSION;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE SEVERITY;
DOUBLE BLIND PROCEDURE;
DRUG DOSE REGIMEN;
DRUG EFFECT;
DRUG EFFICACY;
DRUG SAFETY;
DRUG SCREENING;
DRUG TOLERABILITY;
FEMALE;
GASTROINTESTINAL SYMPTOM;
HEADACHE;
HUMAN;
HYPOMANIA;
MALE;
NAUSEA;
OUTCOMES RESEARCH;
OUTPATIENT CARE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RATING SCALE;
REMISSION;
SCORING SYSTEM;
SEDATION;
SIDE EFFECT;
ADULT;
AMBULATORY CARE;
ANTICONVULSANTS;
ANTIMANIC AGENTS;
BENZOTHIAZOLES;
BIPOLAR DISORDER;
DEPRESSIVE DISORDER, MAJOR;
DOPAMINE AGONISTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
DRUG ADMINISTRATION SCHEDULE;
DRUG RESISTANCE;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
PERSONALITY ASSESSMENT;
PILOT PROJECTS;
THIAZOLES;
|
EID: 1542313961
PISSN: 0002953X
EISSN: None
Source Type: Journal
DOI: 10.1176/appi.ajp.161.3.564 Document Type: Article |
Times cited : (315)
|
References (12)
|